Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.

Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S, Bourre-Tessier J, Clarke A, Baril-Dionne A, Dutz J, Ensworth S, Fifi-Mah A, Fortin PR, Gladman DD, Haaland D, Hanly JG, Hiraki LT, Hussein S, Legault K, Levy D, Lim L, Matsos M, McDonald EG, Medina-Rosas J, Pardo Pardi J, Peschken C, Pineau C, Pope J, Rader T, Reynolds J, Silverman E, Tselios K, Suitner M, Urowitz M, Touma Z, Vinet E, Santesso N.

J Rheumatol. 2018 Oct;45(10):1426-1439. doi: 10.3899/jrheum.171459. Epub 2018 Sep 1.

2.

Methotrexate-The Value of Case Series for Older Drugs.

Ho V, Dutz J.

J Cutan Med Surg. 2018 Sep/Oct;22(5):537. doi: 10.1177/1203475418783711. No abstract available.

PMID:
30168387
3.

Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.

Papp A, Sikora S, Evans M, Song D, Kirchhof M, Miliszewski M, Dutz J.

Burns. 2018 Jun;44(4):807-815. doi: 10.1016/j.burns.2017.10.022. Epub 2018 Apr 4.

PMID:
29627131
4.

Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study.

Eder L, Harvey P, Chandran V, Rosen CF, Dutz J, Elder JT, Rahman P, Ritchlin CT, Rohekar S, Hayday R, Barac S, Feld J, Zisman D, Gladman DD.

J Rheumatol. 2018 Mar;45(3):378-384. doi: 10.3899/jrheum.170379. Epub 2018 Feb 1.

PMID:
29419462
5.

Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Sunderkötter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, Dutz J, Lamprecht P, Mahr A, Aberer E, Werth VP, Wetter DA, Kawana S, Luqmani R, Frances C, Jorizzo J, Watts JR, Metze D, Caproni M, Alpsoy E, Callen JP, Fiorentino D, Merkel PA, Falk RJ, Jennette JC.

Arthritis Rheumatol. 2018 Feb;70(2):171-184. doi: 10.1002/art.40375. Review.

PMID:
29136340
6.

Immunosuppression/Infections across Indications.

Al-Khalili A, Dutz JP.

Curr Probl Dermatol. 2018;53:28-36. doi: 10.1159/000478076. Epub 2017 Nov 7. Review.

PMID:
29131035
7.

Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).

Mehdizadeh A, Alavi A, Alhusayen R, Bauer B, Bechara FG, Bourcier M, Brassard A, Djamei V, Dutz J, George R, Ghias M, Gooderham M, Hamzavi I, Hoffman LK, Hou A, Hu H, Kimball AB, Kirchhof M, Kryzskaya D, Liy Wong MDC, Lowes MA, Lynde CW, McLellen C, Prens E, Prens L, Rogalska T, Sibbald RG, Sisic M, Tan MG, Wong DD.

Exp Dermatol. 2018 Jan;27(1):104-112. doi: 10.1111/exd.13445. Epub 2017 Nov 15.

PMID:
28898476
8.

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.

Lima H, Gooderham M, Dutz J, Lynde C, Chapdelaine H, Ellis A, Gilbert M, Ho V, Papp K, Poulin Y, Sussman G.

Allergy Asthma Clin Immunol. 2017 Aug 24;13:38. doi: 10.1186/s13223-017-0210-0. eCollection 2017.

9.

Case Series: A Kindred With Eruptive Vellus Hair Cysts and Systemic Features.

Ponzo MG, Van Allen MI, Armstrong L, Martinka M, Dutz JP.

J Cutan Med Surg. 2017 Nov/Dec;21(6):564-567. doi: 10.1177/1203475417719044. Epub 2017 Jun 28.

PMID:
28658971
10.

Development of classification criteria for discoid lupus erythematosus: Results of a Delphi exercise.

Elman SA, Joyce C, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, Marinovic B, Szepietowski JC, Dutz J, Werth VP, Merola JF.

J Am Acad Dermatol. 2017 Aug;77(2):261-267. doi: 10.1016/j.jaad.2017.02.030. Epub 2017 Jun 9.

PMID:
28606712
11.

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.

Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, Lynde CW, Papp KA, Rahman P, Rohekar S, Rosen CF, Russell AS, Vender RB, Yeung J, Ziouzina O, Zummer M.

J Rheumatol. 2017 Apr;44(4):519-534. doi: 10.3899/jrheum.161473.

PMID:
28604347
12.

Finger pad tophi in a patient with Raynaud phenomenon.

Zarbafian M, Dutz J.

JAAD Case Rep. 2017 Feb 1;3(1):45-48. doi: 10.1016/j.jdcr.2016.10.013. eCollection 2017 Jan. No abstract available.

13.

IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.

Carruthers MN, Park S, Slack GW, Dalal BI, Skinnider BF, Schaeffer DF, Dutz JP, Law JK, Donnellan F, Marquez V, Seidman M, Wong PC, Mattman A, Chen LY.

Eur J Haematol. 2017 Apr;98(4):378-387. doi: 10.1111/ejh.12842. Epub 2017 Jan 20.

PMID:
28005278
14.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.

Miliszewski MA, Kirchhof MG, Sikora S, Papp A, Dutz JP.

Am J Med. 2016 Nov;129(11):1221-1225. doi: 10.1016/j.amjmed.2016.03.022. Epub 2016 Apr 15.

PMID:
27086495
15.

Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.

Loree JM, Cai E, Sheffield BS, Dutz JP, Villa D, Shepherd LE, Connors JM, Sehn LH, Savage KJ.

Leuk Lymphoma. 2017 Mar;58(3):711-714. doi: 10.1080/10428194.2016.1204657. Epub 2016 Aug 25. No abstract available.

PMID:
27557805
16.

Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response against Influenza A Infections.

Cheng WK, Plumb AW, Lai JC, Abraham N, Dutz JP.

Front Immunol. 2016 Jul 29;7:284. doi: 10.3389/fimmu.2016.00284. eCollection 2016.

17.

Cyclosporine Treatment of Drug-Induced Hypersensitivity Syndrome.

Kirchhof MG, Wong A, Dutz JP.

JAMA Dermatol. 2016 Nov 1;152(11):1254-1257. doi: 10.1001/jamadermatol.2016.2220.

PMID:
27438540
18.

Dr. Roubille, et al reply.

Roubille C, Richer V, Starnino T, McCourt C, McFARLANE A, Fleming P, Siu S, Kraft J, Lynde C, Pope JE, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B.

J Rheumatol. 2016 May;43(5):993-4. doi: 10.3899/jrheum.151347. No abstract available.

PMID:
27134278
19.

Identification of Autoantigen Epitopes in Alopecia Areata.

Wang EHC, Yu M, Breitkopf T, Akhoundsadegh N, Wang X, Shi FT, Leung G, Dutz JP, Shapiro J, McElwee KJ.

J Invest Dermatol. 2016 Aug;136(8):1617-1626. doi: 10.1016/j.jid.2016.04.004. Epub 2016 Apr 16.

20.

Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meeting.

Elman SA, Nyberg F, Furukawa F, Goodfield M, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP, Merola JF.

Int J Womens Dermatol. 2016 Feb 28;2(2):44-45. doi: 10.1016/j.ijwd.2015.12.002. eCollection 2016 Jun. Review.

21.

Tolerogenic effect of mouse fibroblasts on dendritic cells.

Khosravi-Maharlooei M, Pakyari M, Jalili RB, Salimi-Elizei S, Lai JC, Poormasjedi-Meibod M, Kilani RT, Dutz J, Ghahary A.

Immunology. 2016 May;148(1):22-33. doi: 10.1111/imm.12584. Epub 2016 Feb 8.

22.

Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis.

Wong IT, Shojania K, Dutz J, Tsao NW.

Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):153-66. doi: 10.1586/14737167.2016.1133301. Epub 2016 Feb 2. Review.

PMID:
26681527
23.

Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity.

Richer V, Roubille C, Fleming P, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Gulliver WP, Haraoui B, Bissonnette R.

J Cutan Med Surg. 2016 May;20(3):221-7. doi: 10.1177/1203475415616073. Epub 2015 Nov 9. Review.

PMID:
26553732
24.

Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Brown K, Godovannyi A, Ma C, Zhang Y, Ahmadi-Vand Z, Dai C, Gorzelak MA, Chan Y, Chan JM, Lochner A, Dutz JP, Vallance BA, Gibson DL.

ISME J. 2016 Feb;10(2):321-32. doi: 10.1038/ismej.2015.114. Epub 2015 Aug 14.

25.

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B.

J Rheumatol. 2015 Oct;42(10):1767-80. doi: 10.3899/jrheum.141112. Epub 2015 Jul 15. Review.

26.

A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug.

Mansoor I, Lai J, Ranamukhaarachchi S, Schmitt V, Lambert D, Dutz J, Häfeli UO, Stoeber B.

Biomed Microdevices. 2015;17(3):9967. doi: 10.1007/s10544-015-9967-4.

PMID:
26009275
27.

Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire.

Merola JF, Nyberg F, Furukawa F, Goodfield MJ, Hasegawa M, Marinovic B, Szepietowski J, Dutz J, Werth VP.

Lupus Sci Med. 2015 Mar 26;2(1):e000085. doi: 10.1136/lupus-2015-000085. eCollection 2015.

28.

Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis.

Gulliver W, Lynde C, Dutz JP, Vender RB, Yeung J, Bourcier M, Dion PL, Hong CH, Searles G, Poulin Y.

J Cutan Med Surg. 2015 Jan-Feb;19(1):22-7. doi: 10.2310/7750.2014.13151. Epub 2015 Jan 1.

PMID:
25775659
29.

Response to: 'drugs and cardiovascular risk in inflammatory arthritis: another case of glucocorticoid-bashing?' by Dr Boers.

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B.

Ann Rheum Dis. 2015 May;74(5):e34. doi: 10.1136/annrheumdis-2015-207419. Epub 2015 Mar 9. No abstract available.

PMID:
25755140
30.

Insights and advances in chronic urticaria: a Canadian perspective.

Sussman G, Hébert J, Gulliver W, Lynde C, Waserman S, Kanani A, Ben-Shoshan M, Horemans S, Barron C, Betschel S, Yang WH, Dutz J, Shear N, Lacuesta G, Vadas P, Kobayashi K, Lima H, Simons FE.

Allergy Asthma Clin Immunol. 2015 Feb 11;11(1):7. doi: 10.1186/s13223-015-0072-2. eCollection 2015.

31.

Amyopathic dermatomyositis-related thrombophilia.

Kirchhof MG, Dutz JP.

JAMA Dermatol. 2015 May;151(5):559-61. doi: 10.1001/jamadermatol.2014.5070. No abstract available.

PMID:
25587990
32.

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J, Gulliver W, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B.

Ann Rheum Dis. 2015 Mar;74(3):480-9. doi: 10.1136/annrheumdis-2014-206624. Epub 2015 Jan 5. Review.

33.

From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013.

Schultz HY, Dutz JP, Furukawa F, Goodfield MJ, Kuhn A, Lee LA, Nyberg F, Szepietowski JC, Sontheimer RD, Werth VP.

J Invest Dermatol. 2015 Jan;135(1):7-12. doi: 10.1038/jid.2014.316. No abstract available.

34.

Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review.

Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Siu S, Kraft J, Lynde C, Pope JE, Keeling S, Dutz J, Bessette L, Bissonnette R, Haraoui B, Gulliver WP.

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1063-70. doi: 10.1111/jdv.12909. Epub 2014 Dec 10. Review.

PMID:
25490866
35.

Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.

Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE.

Arthritis Care Res (Hoboken). 2015 May;67(6):754-64. doi: 10.1002/acr.22519. Review.

36.

Atrophie blanche: is it associated with venous disease or livedoid vasculopathy?

Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS.

Adv Skin Wound Care. 2014 Nov;27(11):518-24; quiz 525-6. doi: 10.1097/01.ASW.0000455098.98684.95.

37.

Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.

Kirchhof MG, Miliszewski MA, Sikora S, Papp A, Dutz JP.

J Am Acad Dermatol. 2014 Nov;71(5):941-7. doi: 10.1016/j.jaad.2014.07.016. Epub 2014 Jul 30.

PMID:
25087214
38.

The immunopathology of cutaneous lupus erythematosus.

Kirchhof MG, Dutz JP.

Rheum Dis Clin North Am. 2014 Aug;40(3):455-74, viii. doi: 10.1016/j.rdc.2014.04.006. Review.

PMID:
25034156
39.

Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetes.

Marwaha AK, Tan S, Dutz JP.

Clin Immunol. 2014 Sep;154(1):84-9. doi: 10.1016/j.clim.2014.06.006. Epub 2014 Jun 16. Review.

PMID:
24947953
40.

Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis.

Huang Y, Litvinov IV, Wang Y, Su MW, Tu P, Jiang X, Kupper TS, Dutz JP, Sasseville D, Zhou Y.

Oncotarget. 2014 Jun 30;5(12):4418-25.

41.

D-dimer levels as a marker of cutaneous disease activity: case reports of cutaneous polyarteritis nodosa and atypical recurrent urticaria.

Kirchhof MG, Lee AY, Dutz JP.

JAMA Dermatol. 2014 Aug;150(8):880-4. doi: 10.1001/jamadermatol.2013.9944.

PMID:
24695854
42.

Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Cheng WK, Wee K, Kollmann TR, Dutz JP.

Clin Vaccine Immunol. 2014 Mar;21(3):329-39. doi: 10.1128/CVI.00734-13. Epub 2014 Jan 3.

43.

Making necrotizing vasculitis simple.

McCourt C, Dutz JP.

J Cutan Med Surg. 2013 Oct;17 Suppl 1:S40-6. Review.

PMID:
24144255
44.

Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.

Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS.

J Am Acad Dermatol. 2013 Dec;69(6):1033-1042.e1. doi: 10.1016/j.jaad.2013.07.019. Epub 2013 Sep 9. Review.

PMID:
24028907
45.

Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.

Yu R, Broady R, Huang Y, Wang Y, Yu J, Gao M, Levings M, Wei S, Zhang S, Xu A, Su M, Dutz J, Zhang X, Zhou Y.

PLoS One. 2012;7(12):e51040. doi: 10.1371/journal.pone.0051040. Epub 2012 Dec 10.

46.

Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses.

Ryz NR, Patterson SJ, Zhang Y, Ma C, Huang T, Bhinder G, Wu X, Chan J, Glesby A, Sham HP, Dutz JP, Levings MK, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1299-311. doi: 10.1152/ajpgi.00320.2012. Epub 2012 Sep 27.

47.

PP065. dNK and dNK-CM mediated alterations of DNA methylation in extravillous cytotrophoblasts (EVTS).

Hu Y, Yuen R, Eastabrook G, Dutz J, Tan R, von Dadelszen P, Robinson W.

Pregnancy Hypertens. 2012 Jul;2(3):277. doi: 10.1016/j.preghy.2012.04.176. Epub 2012 Jun 13.

PMID:
26105388
48.

Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea.

Ghoreishi M, Vera Kellet C, Dutz JP.

Exp Dermatol. 2012 Jun;21(6):417-9. doi: 10.1111/j.1600-0625.2012.01475.x. Epub 2012 Apr 16.

PMID:
22507598
49.

Molecular markers of early-stage mycosis fungoides.

Zhang Y, Wang Y, Yu R, Huang Y, Su M, Xiao C, Martinka M, Dutz JP, Zhang X, Zheng Z, Zhou Y.

J Invest Dermatol. 2012 Jun;132(6):1698-706. doi: 10.1038/jid.2012.13. Epub 2012 Mar 1.

50.

Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists.

Dupuis EC, Bhole VM, Dutz JP.

Br J Dermatol. 2012 Aug;167(2):448-50. doi: 10.1111/j.1365-2133.2012.10880.x. No abstract available.

PMID:
22309601

Supplemental Content

Support Center